<DOC>
	<DOC>NCT00390780</DOC>
	<brief_summary>The purpose of this study is to evaluate the clinical cure of miconazole Lauriad 50 mg (1x50mg) Bioadhesive buccal tablets compared with clotrimazole troches (5x10mg) after 14 days of treatment (at the test of cure visit, at Day 17-19).</brief_summary>
	<brief_title>Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV Patients</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Miconazole</mesh_term>
	<criteria>Patients with clinical picture of oropharyngeal candidiasis Confirmation of oropharyngeal candidiasis by candida culture positive HIVpositive patients Patients 18 years of age Patients with signs or symptoms of systemic candidiasis Patients with signs or symptoms of esophagitis Pregnant or breastfeeding women Patients who have taken systemic antifungals within the past 30 days Patients who have taken local antifungals within the past 7 days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Miconazole Lauriad</keyword>
	<keyword>Oropharyngeal candidiasis</keyword>
	<keyword>HIV patients</keyword>
	<keyword>Mycology</keyword>
	<keyword>Clinical picture of Oropharyngeal candidiasis</keyword>
	<keyword>Candida culture positive</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>